Abstract:IMPORTANCE: Whole-genome sequencing (WGS) is increasingly applied in clinical medicine and is expected to uncover clinically significant findings regardless of sequencing indication.OBJECTIVES: To examine coverage and concordance of clinically relevant genetic variation provided by WGS technologies; to quantitate inherited disease risk and pharmacogenomic findings in WGS data and resources required for their discovery and interpretation; and to evaluate clinical action prompted by WGS findings.DESIGN, SETTING, AND PARTICIPANTS: An exploratory study of 12 adult participants recruited at Stanford University Medical Center who underwent WGS between November 2011 and March 2012. A multidisciplinary team reviewed all potentially reportable genetic findings. Five physicians proposed initial clinical follow-up based on the genetic findings.MAIN OUTCOMES AND MEASURES: Genome coverage and sequencing platform concordance in different categories of genetic disease risk, person-hours spent curating candidate disease-risk variants, interpretation agreement between trained curators and disease genetics databases, burden of inherited disease risk and pharmacogenomic findings, and burden and interrater agreement of proposed clinical follow-up.RESULTS: Depending on sequencing platform, 10% to 19% of inherited disease genes were not covered to accepted standards for single nucleotide variant discovery. Genotype concordance was high for previously described single nucleotide genetic variants (99%-100%) but low for small insertion/deletion variants (53%-59%). Curation of 90 to 127 genetic variants in each participant required a median of 54 minutes (range, 5-223 minutes) per genetic variant, resulted in moderate classification agreement between professionals (Gross κ, 0.52; 95% CI, 0.40-0.64), and reclassified 69% of genetic variants cataloged as disease causing in mutation databases to variants of uncertain or lesser significance. Two to 6 personal disease-risk findings were discovered in each participant, including 1 frameshift deletion in the BRCA1 gene implicated in hereditary breast and ovarian cancer. Physician review of sequencing findings prompted consideration of a median of 1 to 3 initial diagnostic tests and referrals per participant, with fair interrater agreement about the suitability of WGS findings for clinical follow-up (Fleiss κ, 0.24; P < 001).CONCLUSIONS AND RELEVANCE: In this exploratory study of 12 volunteer adults, the use of WGS was associated with incomplete coverage of inherited disease genes, low reproducibility of detection of genetic variation with the highest potential clinical effects, and uncertainty about clinically reportable findings. In certain cases, WGS will identify clinically actionable genetic variants warranting early medical intervention. These issues should be considered when determining the role of WGS in clinical medicine.

HGV2011: Personalized Genomic Medicine Meets the Incidentalome

HGV2012: Leveraging Next-Generation Technology and Large Datasets to Advance Disease Research

Human Variome Project Country Nodes: Documenting Genetic Information Within a Country

State-of-the-Art Technologies to Interrogate Genetic/Genomic Components of Drug Response

Capturing All Disease-Causing Mutations for Clinical and Research Use: Toward an Effortless System for the Human Variome Project

The Impact of Genomic Variation on Function (IGVF) Consortium

Recommendations for genetic variation data capture in developing countries to ensure a comprehensive worldwide data collection

Assessing structural variation in a personal genome—towards a human reference diploid genome

Clinical Interpretation and Implications of Whole-Genome Sequencing

GenomeMUSter mouse genetic variation service enables multitrait, multipopulation data integration and analysis

Characterizing the Genetic Polymorphisms in 370 Challenging Medically Relevant Genes Using Long-Read Sequencing Data from 41 Human Individuals among 19 Global Populations

Unveiling novel genetic variants in 370 challenging medically relevant genes using the long read sequencing data of 41 samples from 19 global populations

Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases

Big data and innovative bioinformatics approaches in personalized genomic medicine

A 25-year odyssey of genomic technology advances and structural variant discovery

An everlasting role of genetics and genomics in public health: a meeting report of ACGA-HKSMG International Conference on Genetic and Genomic Medicine 2008

Whole genome sequencing in clinical and public health microbiology

Understanding genetic variants in context

A haplotype map of the human genome The International HapMap Consortium

Interlacing Personal and Reference Genomes for Machine Learning Disease-Variant Detection

Deciphering the impact of genomic variation on function